Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Use of preventive cardiovascular drugs ‘markedly insufficient’ in China

A national cardiovascular disease screening project in China revealed fewer than 3 percent of high-risk participants were taking either statins or aspirin—a finding researchers described as a “wake-up call” for middle- and low-income countries which are struggling to combat their worsening CVD risk profiles.

Thumbnail

American women have better control of their hypertension than men

An analysis of sex-related differences in cardiovascular risk factors, treatment and control in the U.S. has revealed women have a better handle on their high blood pressure than men, but they also fare worse in terms of cholesterol and obesity.

Thumbnail

6 months after OHSU heart transplant program implodes, Providence offers a helping hand

Oregon Health & Sciences University might have a chance to revive the heart transplant program it shuttered last August after all four of its cardiologists left the institution, according to reports from the Oregonian and Oregon Live.

Thumbnail

Diabetes deaths trending down with better control of CV risk factors

Diabetes mellitus continues to be linked to higher all-cause and CVD mortality in patients living with the disease, according to work published in the Journal of the American Heart Association Feb. 19. But some of that risk could be mitigated by controlling cardiovascular risk factors, and diabetes-related deaths are down overall.

Thumbnail

‘Inadvertently reversed’ mortality data further muddy debate on paclitaxel PAD treatments

In the latest twist in the debate over the long-term safety of paclitaxel-coated balloons and stents, a correction published Feb. 19 in Circulation said the five-year mortality results of the Zilver PTX randomized trial were “inadvertently reversed”—and that uncoated devices were actually associated with better survival. 

Thumbnail

AHA: Stick to these 4 habits for a healthy BP

The American Heart Association announced on Feb. 20 it launched a series of quick online reference tools for physicians and their patients who struggle with high blood pressure, including a list of four of the most common mistakes hypertensives can make on a daily basis.

Thumbnail

Consistent with ‘obesity paradox,’ overweight AF patients see lower odds of death, stroke

A study published Feb. 14 in the American Journal of Cardiology suggests obese patients with atrial fibrillation (AF) fare better in terms of mortality and stroke events than their non-obese counterparts—a finding that’s in line with the much-contested “obesity paradox."

Startup selling blood from young donors crumbles under FDA scrutiny

A startup that sold young donors’ blood to consumers in several states with the goal of treating conditions such as dementia, Alzheimer’s disease and heart disease has apparently shut down in the wake of an FDA statement that the blood-infusion technique has no scientific merit.